Research Article
Early Kidney Damage Markers after Deferasirox Treatment in Patients with Thalassemia Major: A Case-Control Study
Table 3
Comparison of abnormal U. Alb/CREA (greater than 30) in case and control groups.
| | U. Alb/CREA | Total | value | Less than 30 | 30 to 300 |
| Studied groups | Deferoxamine | Count | 16 | 3 | 19 | 0.64 | Within studied group | 84.2% | 15.8% | 100% | Deferasirox | Count | 16 | 5 | 21 | Within studied group | 76.2% | 23.8% | 100% | Control | Count | 5 | 0 | 5 | Within studied group | 100 | 0 | 100 | Total | Count | 37 | 8 | 45 | Within studied group | 82.2 | 17.8 | 100 |
|
|
Alb: albumin; CREA: creatinine; U: urinary.
|